A trial of proguanil-dapsone in comparison with sulfadoxine-pyrimethamine for the clearance of Plasmodium falciparum infections in Tanzania (Q43752870)

26 November 2017

A trial of proguanil-dapsone in comparison with sulfadoxine-pyrimethamine for the clearance of Plasmodium falciparum infections in Tanzania (English)

1 reference

26 November 2017

0 references

Plasmodium falciparum

0 references

pyrimethamine

0 references

author name string

Mutabingwa TK

1

1 reference

26 November 2017

Maxwell CA

2

1 reference

26 November 2017

Sia IG

3

1 reference

26 November 2017

Msuya FH

4

1 reference

26 November 2017

Mkongewa S

5

1 reference

26 November 2017

Vannithone S

6

1 reference

26 November 2017

Curtis J

7

1 reference

26 November 2017

Curtis CF

8

1 reference

26 November 2017

1 July 2001

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

26 November 2017

1 reference

26 November 2017

95

1 reference

26 November 2017

4

1 reference

26 November 2017

433-438

1 reference

Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria.

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

Resistance of Plasmodium falciparum in Tanganyika to pyrimethamine administered at weekly intervals

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

A comparison of use of a pyrethroid either for house spraying or for bednet treatment against malaria vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

In vivo selection for a specific genotype of dihydropteroate synthetase of Plasmodium falciparum by pyrimethamine-sulfadoxine but not chlorproguanil-dapsone treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

Ex vivo antimalarial activity of proguanil combined with dapsone against cycloguanil-resistant Plasmodium falciparum isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

Plasma concentrations of sulfadoxine-pyrimethamine and of mefloquine during regular long term malaria prophylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

Slow chloroguanide metabolism in Tanzanians compared with white subjects and Asian subjects confirms a decreased CYP2C19 activity in relation to genotype

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

Comparison of chloroquine, pyrimethamine and sulfadoxine, and chlorproguanil and dapsone as treatment for falciparum malaria in pregnant and non-pregnant women, Kakamega District, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

In vivo assessment of the sensitivity of Plasmodium falciparum to sulphadoxine/pyrimethamine combination (Fansidar) in six localities in Tanzania where chloroquine-resistant P. falciparum has been detected

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

Comparison of bednets impregnated with different pyrethroids for their impact on mosquitoes and on re-infection with malaria after clearance of pre-existing infections with chlorproguanil-dapsone

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

Trial of pyrethroid impregnated bednets in an area of Tanzania holoendemic for malaria Part 4. Effects on incidence of malaria infection

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the S-mephenytoin oxidation in Tanzanians.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

Insecticide-impregnated bed nets reduce malaria transmission in rural Zanzibar.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

Pyrimethamine resistant mutations in Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

Resistance to pyrimethamine/sulfadoxine in Plasmodium falciparum in 12 villages in north east Tanzania and a test of chlorproguanil/dapsone

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

Resistance to chloroquine and sulfadoxine-pyrimethamine in Plasmodium falciparum in Muheza district, Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

Chlorproguanil/dapsone for the treatment of non-severe Plasmodium falciparum malaria in Kenya: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

In vitro inhibition of granulopoiesis by 4-amino-4'-hydroxylaminodiphenyl sulfone

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

Clinical pharmacokinetics of antimalarial drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

Chemotherapy for falciparum malaria: the armoury, the problems and the prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

The disposition of oral and intramuscular pyrimethamine/sulphadoxine in Kenyan children with high parasitaemia but clinically non-severe falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

Plasmodium falciparum: mutation pattern in the dihydrofolate reductase-thymidylate synthase genes of Vietnamese isolates, a novel mutation, and coexistence of two clones in a Thai patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

Clinical pharmacokinetics of dapsone

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990207-X

7 January 2021

10.1016/S0035-9203(01)90207-X

Identifiers

DOI

1 reference

26 November 2017

1 reference